Swarm Oncology
PrivateLast Round
Seed
Mar 5, 2026
Total Funding Raised
$10.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Swarm Oncology is a biotechnology company that develops personalized T-cell therapies designed to treat advanced solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Swarm Oncology Comparables
Compare Swarm Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Recursion Pharmaceuticals | 74% | |
| T-Therapeutics | 66% | |
| KSQ Therapeutics | 66% | |
Swarm Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 5, 2026 | ||||
| Grant | Sep 25, 2024 |
Swarm Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delin Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 360% MoM.
- Mar 5, 2026
$8.2M round led by Delin Ventures
Swarm Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Swarm Oncology's valuation, stock price, and market status.